IP Library Granted Patent US 9,399,082
Granted Patent B2
US 9,399,082 · App. 12/937,322 · Granted Jul 26, 2016

Electrospun dextran fibers and devices formed therefrom

Inventors: Gary L. Bowlin (Mechanicsville, VA); David G. Simpson (Mechanicsville, VA); James R. Bowman (Richmond, VA); Stephen W. Rothwell (Columbia, MD)
Assignees: The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.; Virginia Commonwealth University
A61L15/44A61F13/00034A61F13/00063A61L15/28A61L15/32D01D5/0015D01F1/10D01F6/92D01F9/00A61F2013/0054A61F2013/00472A61F2013/00927A61L2300/418A61L2400/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,399,082
App. No.
12/937,322
Granted
Jul 26, 2016
Kind
B2
Abstract

The invention generally relates to dextran fibers which are preferably electrospun and devices formed from such fibers. In particular, such devices may include substances of interest (such as therapeutic substances) associated with the electrospun fibers. Upon exposure to a liquid the electrospun fibers dissolve immediately and the substances of interest are released into the liquid. Exemplary devices include bandages formed from electrospun dextran fibers and associated agents that promote hemostasis, such as thrombin and fibrinogen.

Claims (31)

1. A bandage consisting of a mat consisting of:

electrospun dextran fibers consisting of water-soluble dextran and water, wherein the electrospun dextran fibers are configured to dissolve within three minutes after contact with a bodily fluid; and

dry particles comprising thrombin and dry particles comprising fibrinogen.

2. The bandage of claim 1 , wherein the entire bandage is configured to dissolve within three minutes after saturation with bodily fluid.

3. The bandage of claim 1 , wherein the entire bandage is configured to dissolve within one minute after saturation with liquid blood.

4. The bandage of claim 1 , wherein the mat comprises a plurality of layers of electrospun dextran fibers, and at least some of the particles of thrombin and particles of fibrinogen are present between at least two of the layers.

5. The bandage of claim 4 , wherein the number of layers of electrospun dextran fibers in the mat is ten or fewer.

6. The bandage of claim 4 , wherein the thrombin is human thrombin and the fibrinogen is human fibrinogen.

7. The bandage of claim 1 , wherein the thrombin is human thrombin and the fibrinogen is human fibrinogen.

8. The bandage of claim 1 , wherein the entire bandage is configured to dissolve within 30 seconds of being saturated with blood.

9. The bandage of claim 1 , wherein the entire bandage is configured to dissolve within 15 seconds of being saturated with blood.

10. The bandage of claim 1 , wherein the electrospun dextran fibers include fibers having a diameter ranging from 0.75 microns to 1.25 microns.

11. The bandage of claim 10 , wherein the entire bandage is configured to dissolve within 30 seconds of being saturated with blood.

12. The bandage of claim 10 , wherein the entire bandage is configured to dissolve within 15 seconds of being saturated with blood.

13. A bandage consisting of a mat consisting of:

electrospun dextran fibers that consist of water-soluble dextran and water, wherein the electrospun dextran fibers have an average cross-sectional diameter of about one micron and include fibers having a diameter ranging from about 0.75 microns to about 1.25 microns;

dry particles comprising thrombin; and

dry particles comprising fibrinogen.

14. The bandage of claim 13 , wherein said thrombin and fibrinogen are human thrombin and human fibrinogen.

15. The bandage of claim 13 , wherein the entire bandage is configured to dissolve within 30 seconds of being saturated with blood.

16. The bandage of claim 13 , wherein the entire bandage is configured to dissolve within 15 seconds of being saturated with blood.

17. A bandage consisting of a mat consisting of:

a plurality of layers of electrospun dextran fibers consisting of water-soluble dextran and water, the electrospun dextran fibers having an average cross-sectional diameter of about one micron and comprising fibers having a diameter ranging from about 0.75 microns to about 1.25 microns;

dry particles comprising thrombin; and

dry particles comprising fibrinogen,

wherein at least some of the particles comprising thrombin and at least some of the particles comprising fibrinogen are present between at least two of the layers, and wherein the entire bandage dissolves within three minutes of being saturated with a bodily fluid.

18. The bandage of claim 17 , wherein the number of layers of electrospun dextran fibers in the mat is ten or fewer.

19. The bandage of claim 17 , wherein the entire bandage dissolves within one minute of being saturated with blood.

20. The bandage of claim 17 , wherein the entire bandage dissolves within 30 seconds of being saturated with blood.

21. The bandage of claim 17 , wherein the entire bandage dissolves within 15 seconds of being saturated with blood.

22. The bandage of claim 17 , wherein the thrombin is human thrombin and the fibrinogen is human fibrinogen.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 10, 2011
From: ROTHWELL, STEPHEN
To: UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES
Reel/Frame 026728/0728 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 10, 2011
From: UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES
To: THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC.
Reel/Frame 026728/0792 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 9, 2010
From: BOWLIN, GARY L.; SIMPSON, DAVID G.; BOWMAN, JAMES R.
To: VIRGINIA COMMONWEALTH UNIVERSITY
Reel/Frame 025338/0772 →
Continuity (2)
Provisional Application 61044165 · Apr 11, 2008
Related Publication 20110150973A1 · Jun 23, 2011